World's Best Scientists 2026 revealed!
Armando López-Guillermo

Armando López-Guillermo

D-Index & Metrics

Medicine

D-Index
106
Citations
62724
World Ranking
6375
National Ranking
93

Overview

Armando López-Guillermo is affiliated with the University of Barcelona in Spain, focusing primarily on medicine with significant contributions to pathology and forensic medicine, oncology, genetics, immunology, and cancer research. Their research centers around lymphoma diagnosis and treatment, chronic lymphocytic leukemia, viral-associated cancers and disorders, CAR-T cell therapy, cancer genomics and diagnostics, immune cell function and interaction, as well as immunodeficiency and autoimmune disorders.

Frequent publication venues include Blood, Hematological Oncology, HemaSphere, British Journal of Haematology, and Leukemia & Lymphoma/Leukemia and Lymphoma.

  • Blood
  • Hematological Oncology
  • HemaSphere
  • British Journal of Haematology
  • Leukemia & Lymphoma/Leukemia and Lymphoma

Notable recent papers include:

  • The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee (2022, Blood)
  • Genomic and epigenomic insights into the origin, pathogenesis, and clinical behavior of mantle cell lymphoma subtypes (2020, Blood)
  • High total metabolic tumor volume at baseline predicts survival independent of response to therapy (2020, Blood)
  • Detection of early seeding of Richter transformation in chronic lymphocytic leukemia (2022, Nature Medicine)
  • The proliferative history shapes the DNA methylome of B-cell tumors and predicts clinical outcome (2020, Nature Cancer)

Collaborative work frequently involves Elías Campo, Ferran Nadeu, Eva Giné, Pablo Mozas, and Sílvia Beà.

  • Elías Campo
  • Ferran Nadeu
  • Eva Giné
  • Pablo Mozas
  • Sílvia Beà

The scientist's publications reflect extensive interdisciplinary research bridging clinical and molecular aspects of hematological malignancies.

Best Publications

  • The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma

    Andreas Rosenwald;George Wright;Wing C. Chan;Wing C. Chan;Joseph M. Connors

  • Pan-cancer analysis of whole genomes

    Peter J. Campbell;Gad Getz;Jan O. Korbel;Joshua M. Stuart

  • CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group

    Michael Pfreundschuh;Lorenz Trümper;Anders Österborg;Ruth Pettengell

  • Follicular lymphoma international prognostic index.

    Philippe Solal-Céligny;Pascal Roy;Philippe Colombat;Josephine White

  • Stromal gene signatures in large-B-cell lymphomas

    G Lenz;G Wright;S S Dave;W Xiao

  • Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia

    Xose S. Puente;Magda Pinyol;Víctor Quesada;Laura Conde

  • Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma

    Roland Schmitz;George W. Wright;Da Wei Huang;Calvin A. Johnson

  • ZAP-70 Expression as a Surrogate for Immunoglobulin-Variable-Region Mutations in Chronic Lymphocytic Leukemia

    Marta Crespo;Francesc Bosch;Neus Villamor;Beatriz Bellosillo

  • Adult haemophagocytic syndrome

    Manuel Ramos-Casals;Pilar Brito-Zerón;Armando López-Guillermo;Munther A Khamashta

  • Molecular Diagnosis of Primary Mediastinal B Cell Lymphoma Identifies a Clinically Favorable Subgroup of Diffuse Large B Cell Lymphoma Related to Hodgkin Lymphoma

    Andreas Rosenwald;George Wright;Karen Leroy;Xin-You Yu

  • Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial.

    Gilles Salles;John Francis Seymour;Fritz Offner;Armando Lopez-Guillermo

  • Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia.

    Víctor Quesada;Laura Conde;Neus Villamor;Gonzalo R Ordóñez

  • Non-coding recurrent mutations in chronic lymphocytic leukaemia

    Xose S. Puente;Silvia Beà;Rafael Valdés-Mas;Neus Villamor

  • Patterns of somatic structural variation in human cancer genomes

    Yilong Li;Nicola D Roberts;Jeremiah A Wala;Jeremiah A Wala;Ofer Shapira;Ofer Shapira

  • CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group.

    Michael Pfreundschuh;Evelyn Kuhnt;Lorenz Trümper;Anders Österborg

  • Follicular Lymphoma International Prognostic Index 2: A New Prognostic Index for Follicular Lymphoma Developed by the International Follicular Lymphoma Prognostic Factor Project

    Massimo Federico;Monica Bellei;Luigi Marcheselli;Stefano Luminari

  • Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    H Tilly;M Gomes da Silva;U Vitolo;A Jack

  • Intravascular lymphoma: clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the 'cutaneous variant'.

    Andrés J. M. Ferreri;Elías Campo;John F. Seymour;Rein Willemze

  • Epigenomic analysis detects widespread gene-body DNA hypomethylation in chronic lymphocytic leukemia

    Marta Kulis;Simon Heath;Marina Bibikova;Ana C Queirós

  • Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue.

    Emanuele Zucca;Annarita Conconi;Ennio Pedrinis;Sergio Cortelazzo

Frequent Co-Authors

Elias Campo
Elias Campo University of Barcelona
Neus Villamor
Neus Villamor University of Barcelona
Emili Montserrat
Emili Montserrat University of Barcelona
Dolors Colomer
Dolors Colomer University of Barcelona
Sílvia Beà
Sílvia Beà University of Barcelona
Itziar Salaverria
Itziar Salaverria University of Barcelona
Carlos López-Otín
Carlos López-Otín University of Oviedo
Xose S. Puente
Xose S. Puente University of Oviedo
Andreas Rosenwald
Andreas Rosenwald University of Würzburg
German Ott
German Ott Robert Bosch (Germany)

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine doesn’t always mean pursuing a traditional MD. Numerous online degrees and alternative pathways can lead to rewarding roles in the healthcare field. For those looking to enter healthcare administration, pursuing a degree in healthcare administration can open doors to leadership positions within hospitals, clinics, or public health organizations.

If you’re interested in the technical side, financial aid for medical billing and coding is available from many accredited online programs, helping to reduce costs and making this in-demand career more accessible.

Nursing is another popular healthcare pathway. Some nursing schools that don't require teas test offer streamlined admissions, allowing students to focus on their core nursing education without the stress of entrance exams. For registered nurses aiming to advance, adn to msn bridge programs enable RNs with an associate degree to complete their master’s degree faster and online.

These varied pathways support a wide range of interests and backgrounds, making healthcare careers more flexible and accessible than ever before.

Best Scientists Citing Armando López-Guillermo

Trending Scientists

Recently Published Articles